Dalbavancin in Bone and Joint Infections: A Systematic Review

Background: Approved for acute bacterial skin and skin structure infections, dalbavancin (DBV) has gradually acquired over the years a role as an off-label treatment for several infections caused by Gram-positive bacteria even in other anatomical sites. Osteoarticular (OA) infections are one of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovatti, Sofia, Tiecco, Giorgio, Mulé, Alice, Rossi, Luca, Sforza, Anita, Salvi, Martina, Signorini, Liana, Castelli, Francesco, Quiros-Roldan, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385685/
https://www.ncbi.nlm.nih.gov/pubmed/37513919
http://dx.doi.org/10.3390/ph16071005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385685/
https://www.ncbi.nlm.nih.gov/pubmed/37513919
http://dx.doi.org/10.3390/ph16071005

Ejemplares similares